Handelsbanken Fonder
EVH icon

Handelsbanken Fonder’s Evolent Health EVH Stock Holding History

Handelsbanken Fonder’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-25,100
Closed -$212K – 1517
2025
Q3 		$212K Hold
25,100
– – ﹤0.01% 1477
2025
Q2 		$283K Sell
25,100
-1,200
-5% -$11K ﹤0.01% 1434
2025
Q1 		$249K Hold
26,300
– – ﹤0.01% 1454
2024
Q4 		$296K Buy
26,300
+5,400
+26% +$94.9K ﹤0.01% 1453
2024
Q3 		$591K Hold
20,900
– – ﹤0.01% 1181
2024
Q2 		$400K Buy
20,900
+2,700
+15% +$69K ﹤0.01% 1257
2024
Q1 		$597K Hold
18,200
– – ﹤0.01% 1078
2023
Q4 		$601K Buy
18,200
+3,300
+22% +$93.4K ﹤0.01% 1055
2023
Q3 		$406K Hold
14,900
– – ﹤0.01% 1153
2023
Q2 		$451K Hold
14,900
– – ﹤0.01% 1118
2023
Q1 		$484K Hold
14,900
– – ﹤0.01% 1019
2022
Q4 		$418K Hold
14,900
– – ﹤0.01% 1052
2022
Q3 		$535K Hold
14,900
– – ﹤0.01% 923
2022
Q2 		$458K Hold
14,900
– – ﹤0.01% 1076
2022
Q1 		$481K Sell
14,900
-4,500
-23% -$118K ﹤0.01% 1232
2021
Q4 		$537K Sell
19,400
-2,500
-11% -$71.7K ﹤0.01% 1297
2021
Q3 		$679K Buy
21,900
+3,100
+16% +$74.4K ﹤0.01% 1137
2021
Q2 		$397K Buy
18,800
+5,900
+46% +$118K ﹤0.01% 1533
2021
Q1 		$261K Hold
12,900
– – ﹤0.01% 1487
2020
Q4 		$207K Hold
12,900
– – ﹤0.01% 1514
2020
Q3 		$160K Hold
12,900
– – ﹤0.01% 1418
2020
Q2 		$92K Buy
+12,900
New +$86.4K ﹤0.01% 1428
2019
Q4 		– Sell
-750,000
Closed -$5.39M – 185
2019
Q3 		$5.39M Sell
750,000
-50,000
-6% -$359K 0.11% 145
2019
Q2 		$6.36M Buy
800,000
+325,000
+68% +$3.85M 0.12% 155
2019
Q1 		$5.98M Buy
+475,000
New +$7.52M 0.12% 148
2017
Q4 		– Sell
-245,000
Closed -$4.36M – 199
2017
Q3 		$4.36M Hold
245,000
– – 0.1% 137
2017
Q2 		$6.21M Buy
245,000
+165,000
+206% +$3.97M 0.16% 118
2017
Q1 		$1.78M Buy
+80,000
New +$1.54M 0.05% 145

Other funds holding EVH

CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Handelsbanken Fonder's EVH Position: Q4 2025 in Review

Handelsbanken Fonder sold out of Evolent Health (EVH) in Q4 2025, closing a stake of 25,100 shares — an estimated $212K sold.

Handelsbanken Fonder first reported a position in EVH in Q1 2017 and held it in 28 quarters. The position peaked at $6.36M in Q2 2019. 215 funds tracked by Wall St. Rank hold EVH as of Q4 2025.

  • Handelsbanken Fonder reported no remaining Evolent Health position as of Q4 2025 after selling out during the quarter.
  • Handelsbanken Fonder sold 25,100 Evolent Health shares in Q4 2025, an estimated $212K.
  • Handelsbanken Fonder first reported a position in Evolent Health in Q1 2017 and held it in 28 quarters.
  • Handelsbanken Fonder's Evolent Health position peaked at $6.36M in Q2 2019.
  • 215 funds tracked by Wall St. Rank held Evolent Health as of Q4 2025.

Based on Handelsbanken Fonder's 13F filing for Q4 2025, filed 6 Feb 2026.